These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis. Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits. Mengeloğlu FZ; Küçükbayrak A; Bucak YY; Erdurmuş M; Taş T; Özyalvaçlı G; Bayram R; Bucak Ö; Akdeniz H J Ocul Pharmacol Ther; 2013 Dec; 29(10):893-9. PubMed ID: 24070366 [TBL] [Abstract][Full Text] [Related]
29. Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin. Insler MS; Fish LA; Silbernagel J; Hobden JA; O'Callaghan RJ; Hill JM Ophthalmology; 1991 Nov; 98(11):1690-2. PubMed ID: 1800931 [TBL] [Abstract][Full Text] [Related]
30. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004 [TBL] [Abstract][Full Text] [Related]
31. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Panda A; Ahuja R; Sastry SS Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137 [TBL] [Abstract][Full Text] [Related]
32. Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis. Barequet IS; Bourla N; Pessach YN; Safrin M; Yankovich D; Ohman DE; Rosner M; Kessler E Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):223-9. PubMed ID: 21947265 [TBL] [Abstract][Full Text] [Related]
33. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits. Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776 [TBL] [Abstract][Full Text] [Related]
38. Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis. Koh S; Maeda N; Nishida K J AAPOS; 2014 Feb; 18(1):99-101. PubMed ID: 24568999 [TBL] [Abstract][Full Text] [Related]
39. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits. Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468 [TBL] [Abstract][Full Text] [Related]